SCHEMBL14865875

SCHEMBL14865875

C/C=N\C(C)=C\C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12153789 1.00
SCHEMBL15698053 1.00
SCHEMBL23572364 1.00
SCHEMBL24715857 0.79
SCHEMBL15721581 0.76
SCHEMBL15679930 0.76
SCHEMBL15488916 0.76
SCHEMBL24861022 0.74
SCHEMBL21320110 0.74
SCHEMBL20080610 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246128-A1 BICYCLE TOPOISOMERASE I INHIBITING COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2021-08-12 US disclosed
WO-2021011641-A1 CRYSTALLINE FORMS OF SOMATOSTATIN MODULATORS Crinetics Pharmaceuticals, Inc. (US) 2021-01-21 WO disclosed
WO-2020219729-A1 PAPD5 INHIBITORS AND METHODS OF USE THEREOF CHILDREN'S MEDICAL CENTER CORPORATION (US) 2020-10-29 WO disclosed
US-10544138-B2 Tricyclic kinase inhibitors of MELK and methods of use DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-01-28 US disclosed
US-8748429-B2 CGRP receptor antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2014-06-10 US disclosed
US-20130096130-A1 CGRP Receptor Antagonists BRISTOL-MYERS SQUIBB COMPANY 2013-04-18 US disclosed